Superior Essex Inc. and Furukawa Electric Co., Ltd. Announce Intent to Form European Joint Venture
Essex Magnet Wire, a division of Superior Essex Inc., and Furukawa Electric Co., Ltd. (“Furukawa Electric”) announced today their intent to form a joint venture to supply a new type of winding high-voltage wire (HVW) primarily to the automotive industry throughout the European Economic Area.
The joint venture will manufacture, market, sell, and distribute HVWs that are used in electrical-driving motors, generators, and reactors for automotive vehicles. This endeavor combines the global resources and technical expertise of Essex Magnet Wire and Furukawa Electric, i.e., Essex Magnet Wire’s European sales force and manufacturing operations and Furukawa Electric’s relevant technology, which Furukawa Electric will license to the joint venture, to supply a new type of HVW to automotive customers in Europe. Based in Bad Arolsen, Germany, the joint venture will operate under the name Essex Furukawa Magnet Wire Europe. Although Essex Magnet Wire will be the majority shareholder of the joint venture, the parties expect to operate the joint venture in the spirit of a true commercial partnership. The formation of the joint venture is expected to close in the first quarter 2017, following the execution of definitive agreements and the receipt of required regulatory approvals.
About Essex Magnet Wire—a division of Superior Essex Inc.
Superior Essex Inc. manufactures and distributes copper and aluminum wire and cable products that power and connect everything from classrooms and data centers to electric vehicles and mobile devices. For over 85 years, Superior Essex has been serving the magnet wire/winding wire, communications, and energy, related distribution markets. Its Essex Magnet Wire division holds top market shares in North America and Europe providing the automotive, industrial, energy and commercial and residential markets with seamless delivery and service from facilities in seven countries. Dedicated to resolving customer’s challenges while positively impacting our communities worldwide, Superior Essex, and its divisions, continue to push boundaries in technology, sustainability, and innovation. For more information, visit superioressex.com.
About Furukawa Electric Co., Ltd.
Furukawa Electric Co., Ltd. (TSE: 5801) started business in 1884, when its copper-smelting facility and wire manufacturing factory was established. Since then Furukawa Electric has become pioneers in the latest technologies by addressing diverse technological issues. Furukawa Electric has released products in a number of areas, including telecommunications, electronics, automobiles, and construction, with the three types of materials it works with at their core, namely, optics, plastics, and metals. Many of these products have attained the top global market share, and all of its products have contributed to society in numerous business areas. Furukawa Electric reported consolidated revenues of 874.8 billion yen for the fiscal year ended March 31, 2016. To learn more about Furukawa Electric, please visit furukawaelectric.com.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
IL-GILEAD-SCIENCES21.10.2018 00:32 | pressemeddelelse
Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting
CA-TRUE-RELIGION19.10.2018 19:39 | pressemeddelelse
Manchester United and True Religion Launch Denim Range
ARCH-INSURANCE19.10.2018 15:12 | pressemeddelelse
Arch Insurance Announces Strategic Leadership Changes
MA-TAKEDA-PHARMACEUTICAL19.10.2018 14:02 | pressemeddelelse
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
VERTEX-PHARMACEUTICALS19.10.2018 13:56 | pressemeddelelse
Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene
TX-SCHLUMBERGER-LIMITED19.10.2018 13:02 | pressemeddelelse
Schlumberger Announces Third-Quarter 2018 Results
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum